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Experimental Design
• Exposure:
– From “in utero” to adult age (up to 4 months)
– Arsenate/other chemicals in drinking water
– Doses: 0.1 - 1 - 10 mg As/L
– Diet: variable proteins content
• Tissues
– RNA extraction and characterization
• Hybridization
– Macroarray: Mouse Cancer 1.2  and Toxicology 1.2 clusters (AtlasTM,
Clontech, U.S.A) using [33P]-αdATP (1.185 genes) 
– Microarray: Mouse Applied Biosystems Expression Array System using a
chemiluminescence chemistry (32.000 genes).
• Quantitative Real-Time PCR
– TaqMan Gene Expression Assays (Applied Biosystems) for validating 
microarray results. 
• Data analyses
Diet The modulation of gene expression in different tissues was not only depending on the exposure to arsenate but mainly regulated by the level 
of proteins in the diet.
Doses Apparently low doses are more efficient than higher doses in modulating gene expression in tissues of mice chronically exposed to arsenate.
Tissues Only few genes commonly modulated in different tissues.
Acute/Chronic 4-24 hours/4 months: in the liver, at 4 months only up modulated genes, few  in common with 24 hours.
Mixtures The co-exposure to atrazine and arsenate significantly modulates the transcriptional activation of genes in bone marrow cells differently than arsenate or atrazine administered alone.
Gender The molecular mechanisms triggered by arsenic in tissues are totally different in males and females.
Metabolism IAs/DMA: specific tissues response for chemical species (i.g. gene modulation in lungs by DMA)
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